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Abstract
Background: Mycobacterium species are grown using specific media that increase laboratory cost, thus hampering their
diffusion in resource-limited countries. Preliminary data suggested that versatile blood agar may be also used for
mycobacterial culture.
Methodology: We examined the growth of 41 different Mycobacterium species on 5% blood agar. Over a 24-month period
we analysed isolation of mycobacteria after parallel inoculation of clinical specimens into both a reference automated
system (BACTEC 9000 MB broth) and 5% blood agar slant tubes, after NaOH decontamination, and compared the cost of
performing 1,000 analyses using these two techniques.
Conclusions: Mycobacterium reference species cultured on blood agar, with the exception of Mycobacterium ulcerans.
Inoculation of 1,634 specimens yielded 95 Mycobacterium isolates. Blood agar performed significantly more efficiently than
BACTEC 9000 MB broth (94 vs 88 isolates, P=0.03). Decontamination of Candida albicans in 5 specimens by addition of
amphotericin B in blood agar yielded one more M. tuberculosis isolate that could not be isolated in BACTEC broth. Uneven
distribution of time to culture positivity for M. tuberculosis had a median (range) of 1965 days using blood agar and 2666
days using BACTEC 9000 MB broth. Cost for 1,000 analyses in France was estimated to be of 1,913 euros using the blood
agar method and 8,990 euros using the BACTEC 9000 MB method. Blood agar should be regarded as a first-line medium for
culturing Mycobacterium species. It saves time, is cost-effective, is more sensitive than, and at least as rapid as the
automated method. This is of particular importance for resource-limited countries in which the prevalence of tuberculosis is
high.
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Introduction
Specific media, such as egg-based media (e.g. Lowenstein Jensen
medium), agar-based media (e.g. Middlebrook media) and liquid
media (e.g. Middlebrook and BACTEC broths) are recommended
for culturing Mycobacterium species [1]. Such requirements pose
logistic and economic problems, especially in resource-limited
areas where bacteriological culture facilities are few and the
prevalence of mycobacterial infections, notably tuberculosis, is
high. The cost of automatic detection using reference automated
mycobacterial culture systems is high. The rationale for using
specific media for culturing mycobacteria was to ensure the growth
of Mycobacterium species without supporting the growth of
contaminants. However, effective decontamination procedures
have been developed for non-sterile samples [1]. We therefore
questioned the utility and cost-effectiveness of an alternative
medium, blood-agar, for the isolation and growth of Mycobacterium
species as it is relatively commonly available and inexpensive.
Moreover, it may save time and expense by avoiding duplicate
inoculation for sterile specimens when other microorganisms are
suspected. Sporadic papers have reported the isolation of
Mycobacterium tuberculosis on standard blood-agar incubated for 3
weeks or more [2,3] and proof-of-principle studies have been
published [4,5]. However, it has not been evaluated whether blood
agar is useful for the isolation of opportunistic non-tuberculous
Mycobacterium species, what the contamination frequency is for non
sterile samples, and what the cost-effectiveness of such a diagnostic
approach is.
The data presented herein show that ordinary blood agar
medium can support the growth of Mycobacterium species other
than Mycobacterium ulcerans, in a cost-effective way and that
contamination is rarely a problem if decontamination procedures
are strictly followed.
Methods
Mycobacterium strains
Forty-one reference strains of Mycobacterium species (Institut
Pasteur, Paris, France and American Tissue Culture Collection,
Rockville, Maryland) were tested (Table 1). An aliquot of 10 mlo f
stock culture (concentration 10
2 colony-forming units/ml) was
streaked simultaneously onto Middlebrook 7H10 agar (Becton
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blood-agar slant tubes containing 21 g/l peptones, 1 g/l starch,
5 g/l NaCl, 12 g/l agar and 5% defibrinated sheep blood, pH 7.3
(Bio Technologie Applique ´e, Dinan, France). The agar slants so
inoculated were incubated for 28 days. Each culture was
performed in triplicate.
Clinical specimens
The study was approved by the local ethical committee
according to French laws. Between January 2005 and December
2006, the sensitivity and contamination rate of cultured Mycobac-
terium species from clinical specimens on blood agar media was
prospectively evaluated by parallel inoculation of eligible speci-
mens into BACTEC 9000 MB broth. Eligible specimens com-
prised Ziehl-Neelsen positive respiratory tract specimens and all
other specimens except cerebrospinal fluid, blood and bone
marrow regardless of the Ziehl-Neelsen staining result. Prior to
inoculation, respiratory and faecal samples were decontaminated
as described previously [6]. In brief, an average 1 ml of
contaminated specimen was mixed with 1 ml of decontamination
solution (NaOH, 2% w/vol final concentration; N-acetyl-L-
cystein, 0.5% w/vol final concentration) by gentle vortexing for
15 seconds and incubated at room temperature for 15 min. After
gentle vortexing, 48 ml of phosphate buffered saline (PBS) pH 6.8
(BioMe ´rieux, La Balme les Grottes, France) were added and the
suspension was centrifuged at 2,8449 g for 20 minutes. The
supernatant was discarded and the pellet was resuspended into
5 ml sterile PBS; 2 ml were inoculated into a BACTEC 9000 MD
broth bottle and 0.2 ml were inoculated onto blood agar. The
samples obtained from cutaneous and lymph node biopsies were
crushed aseptically into Penta mixture (Becton Dickinson Di-
agnostic Systems) and sterile isotonic water, respectively. All
samples were inoculated in parallel into BACTEC 9000 MD
broth (Becton Dickinson Diagnostic Systems) as well as onto 5%
sheep blood agar in slant tubes incubated at 37uC and 30uC
for skin biopsy specimens. Time of positive detection in the
BACTEC system and time to grow colonies on blood agar as
monitored by naked eye examination of tubes three times a week,
were observed for 8 weeks. Isolates were identified after Ziehl-
Neelsen staining by phenotypic analyses and partial rpoB gene
sequence analysis [7,8].
Economic evaluation
We compared the cost of inoculation onto sheep blood agar
in tube and into the BACTEC system by incorporating the cost
of blood agar in tube, the cost of either BACTEC system
or incubator with a 5-year period for depreciation and the
averaged cost of labour on the basis of 2006 salary in France.
We also evaluated the cost of labour for blood agar-based
technique in Algeria, Brazil, India, Laos and Malawi using 2006
salaries.
Statistical analyses
Numerical variables were compared using the Fisher’s exact
test.
Results
Mycobacterium strains
M. ulcerans grew only on Middlebrook 7H10 agar and M.
haemophilum grew only on blood agar media. All other Mycobacterium
species tested grew equally well on both blood agar and
Middlebrook 7H10 agar media (Table 1). Compared to those
observed in blood agar media, Mycobacterium gordonae, Mycobacterium
szulgai, Mycobacterium xenopi, and Mycobacterium intracellulare grew
more rapidly on Middlebrook 7H10 agar. Mycobacterium chelonae
grew more rapidly on blood agar. Results were identical in
triplicate experiments.
Clinical specimens
A total of 7,419 clinical specimens submitted for the isolation
and culture of mycobacteria during this 24-month period yielded
156 Mycobacterium isolates (prevalence=2.1%) comprising 118 M.
tuberculosis complex isolates and 38 non-tuberculous isolates. 1,634
clinical specimens eligible for and included in the present study
yielded 95 Mycobacterium isolates (prevalence=5.8%) (Table 2)
including 84 M. tuberculosis organisms isolated from 48 samples
obtained from the respiratory tract, 27 from lymph nodes, 7 from
biopsies and 2 from stools. Sixteen M. tuberculosis (19%) isolates
resistant to streptomycin included two multi-drug resistant (MDR)
(2.4%) isolates and no extensively drug-resistant isolate. A total of
5 M. avium isolates were cultured from 3 samples obtained from the
respiratory tract, 1 from lymph node and 1 from stools. M. xenopi
was cultured from the respiratory tract of one patient and a knee
prosthesis abscess in another patient. M. marinum was cultured
from a skin biopsy in one patient. M. fortuitum was cultured from
a bone biopsy in one patient. M. chelonae and Mycobacterium
massiliense were cultured from respiratory tract specimens in one
patient each. Blood agar inoculation missed one M. tuberculosis
complex isolate (1%) which grew from a lymph node after 32-day
inoculation in BACTEC broth only. BACTEC broth inoculation
missed 7 Mycobacterium organisms (7.3%) which were isolated
on blood agar only and included 6 M. tuberculosis complex and 1
M. marinum organisms. The number of missed M. tuberculosis
isolates was significantly higher with the BACTEC than the blood-
agar technique (P=0.03). M. tuberculosis complex isolates missed by
the BACTEC inoculation included 4 isolates from lymph nodes,
1 from a lung biopsy and 1 from a respiratory tract sample
contaminated with Candida albicans. Indeed, 5 respiratory tract
specimens were found to have been contaminated (contamination
rate of respiratory specimens, 1.5%) with Candida albicans on both
tested media. One of these specimens was inoculated again on
Author Summary
Mycobacteria are organisms responsible for animal and
human infections comprising tuberculosis due to Myco-
bacterium tuberculosis and other opportunistic infections.
Such infections require specific antibiotic treatment and
prevention of secondary cases in the occurrence of
pulmonary tuberculosis. The accurate diagnosis of myco-
bacteria infection is therefore of prime importance.
Isolation and culture of mycobacteria from diseased
clinical specimens is the gold standard for diagnosis. It
relied for decades on the use of specific isolation media,
resulting in most laboratories not attempting such di-
agnosis. Alternatively, specific automates and culture
broths are available only in developed countries. We
herein demonstrate that blood agar, a basic medium
widely and routinely used in laboratories worldwide, is
suitable for the isolation and culture of mycobacteria
encountered in human pathology, including tuberculosis.
It performed at least as well as reference culture broth.
Morever, using blood agar was cost-effective. Blood agar
should be recommended as a routine medium for the
isolation of most pathogenic organisms, including myco-
bacteria, both in developing and developed countries.
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and grew M. tuberculosis. The median time to culture positivity
of M. tuberculosis was 1965 days (range: 3–45) using blood-agar
and 2666 days (range: 7–39) using reference automated
mycobacterial culture (P=0.1). No difference was observed in
culturing streptomycin-resistant, MDR and antibiotic-susceptible
M. tuberculosis isolates.
Economic evaluation
In France the annual cost for performing 1,000 BACTEC
analyses including incubator/alert machine for 2,092 J, reagents
for 6,090 J and labour for 78 J gave a total of 8,990 J. For the
blood-agar method the annual cost for performing 1,000 analyses
included one incubator for 57 J, reagents for 1,076 J and labour
for 780 J gave a total of 1,913 J. In other countries, the estimated
Table 1. Growth of 40 Mycobacterium spp. reference strains (alphabetical order) on Middlebrook agar and sheep-blood agar.
Days for colonies to be visible on
Mycobacterial species Strain Blood agar Middlebrook agar Growth temperature (uC)
M. abcessus CIP 104536
T 11 3 7
M. aichiense ATCC 27280 7 7 37
M. aurum CIP 104465
T 11 3 7
M. avium subsp. avium CIP 104244
T 99 3 7
M. bohemicum CIP 105811
T 66 3 7
M. bolletii CIP 108541
T 66 3 7
M. branderi CIP 104592
T 66 3 7
M. chelonae CIP 104535
T 11 14 37
M. conspicuum CIP 105165
T 99 3 7
M. fallax CIP 8139
T 33 3 0
M. flavescens CIP 104533
T 33 3 7
M. fortuitum ATCC 49404 2 2 37
M. fortuitum subsp F ATCC 49403 2 2 37
M. fortuitum subsp F CIP 104534
T 22 3 0
M. gordonae CIP 104529
T 96 3 0
M. haemophilum CIP 105049
T 9 No growth 30
M. heidelbergense CIP 105424
T 99 3 7
M. hiberniae CIP 104537
T 99 3 7
M. imunogenum ATCC 1066845 6 7 37
M. interjectum ATCC 51457 6 6 37
M. intermedium CIP 104542
T 66 3 7
M. intracellulare CIP 104243
T 14 6 37
M. kansasii CIP 104589
T 15 9 37
M. mageritense CIP 104973
T 66 3 7
M. marinum CIP 104528
T 66 3 0
M. mucogenicum ATCC 49650 6 6 37
M. mucogenium CIP 105223
T 22 3 0
M. novocastrence CIP 105546
T 66 3 7
M. parafortuitum ATCC 19686 3 3 37
M. peregrinum CIP 105382
T 91 0 3 7
M. phlei CIP 105389
T 11 3 7
M. septicum ATCC 700731 2 2 37
M. simiae CIP 104531
T 66 3 7
M. smegmatis CIP 104444
T 11 3 7
M. szulgai CIP 104532
T 16 11 37
M. terrae CIP 104321
T 66 3 7
M. ulcerans CIP 105425
T No growth 14 37
M. vaccae CIP 105934
T 22 3 7
M. wolinsky CIP 106348
T 66 3 0
M. xenopi CIP 104035
T 24 16 37
The number of days before colonies became visible is indicated for each species on each growth medium. ATCC, American Tissue Culture Collections; CIP, Collection de
l’Institut Pasteur.
doi:10.1371/journal.pntd.0000083.t001
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from 37 J in Algeria and Brazil, 40.5 J in Malawi, 45 J in India
and Laos and 50 J in Romania. The cost of reagents is variable, in
many laboratories (such as in Laos), farm animals are blood
sampled by technicians to generate blood agar at very low cost.
Discussion
This study extends the findings of previous anecdotal [2,3–9]
and proof-of-principle studies [4,5–13] and demonstrates that
blood-agar in slant tubes outperforms the reference automated
method for isolation of mycobacteria from clinical specimens.
Most Mycobacterium species encountered in the clinical microbiol-
ogy laboratory readily grew onto 5% sheep-blood agar, except for
M. ulcerans, a fastidious organism which is rarely isolated from
diseased tissues in patients with Buruli ulcer [14]. The character-
isation of adverse factors preventing this species culture on blood
agar was beyond the scope of this study. These data extend
previous information to a number of Mycobacterium species
routinely encountered in microbiological laboratory practice,
regardless of whether the species were slow or rapid growers.
Previous study indeed demonstrated that blood-agar was at least
equivalent to egg-based medium for the isolation of M. tuberculosis
from respiratory and lymph node specimens [5]. In present study,
the sensitivity of blood agar for culturing Mycobacterium isolates
from clinical specimens was 98.9% (1/95 isolate was cultured in
the BACTEC bottles only). This M. tuberculosis isolate had been
recovered from a diseased lymph node and there was no obvious
reason for the lack of growth on blood agar. No clinical material
was left in order to reproduce the parallel inoculation. Seven M.
tuberculosis isolates made on blood-agar medium failed to grow in
BACTEC bottles, thus giving a significantly lower sensitivity
(92.6%) of the BACTEC medium compared to blood agar for the
isolation of mycobacteria. M. marinum grew in blood agar
incubated at 30uC and not in BACTEC incubated at 37uC. This
observation agrees with the reported optimal growth temperature
of this species and that some M. marinum isolates grow better on
blood than on Middlebrook agar [15]. Blood agar slants offer the
possibility of incubation at different temperatures whereas all
automatic systems, including BACTEC, do not allow for such
modulation. We suggest that the M. tuberculosis complex isolates
which did not grow in BACTEC bottles, failed to grow as the
inocula were too small to promote growth in the 40-ml volume of
broth but large enough to promote minute growth on solid
medium. The contamination frequency of 1.5% on blood agar for
respiratory tract specimens was low and warrants further
evaluation in other laboratories. We used amphotericin B to
decontaminate samples inoculated on blood agar, whilst ampho-
tericin B cannot be used in BACTEC system as it interferes with
the detection system. Accordingly, one respiratory tract M.
tuberculosis isolate was made on blood agar after amphotericin B
decontamination.
The median time to culture positivity for M. tuberculosis was
shorter, albeit non-significantly, for blood-agar than for the
automated mycobacterial culture. In our experience, the slant
tube format prevented the otherwise rapid desiccation of blood-
agar and allowed long-term incubation of the clinical specimen at
37uC. It also minimized the risk of infection for the laboratory
workers [16]. These data indicate that blood-agar in slant tubes is
a suitable alternative medium for the routine isolation of
mycobacteria for clinical specimens.
Our economic analysis demonstrated that, at least in France,
blood-agar was 4.7 times less expensive than a reference
automated mycobacterial culture (BACTEC broth) system. We
Table 2. Comparative analysis of reference BACTEC and blood-agar for the isolation of mycobacteria from clinical specimens.
BACTEC Blood-agar P
Specimens
Respiratory tract 328 328 1
Other specimens 1,306 1,306 1
Total 1,634 1,634 1
Isolates
Respiratory tract
M. tuberculosis (n=48) 46 48 0.2
Other species (n=6) 6 6 1
Total (n=54) 52 54 0.2
Other specimens
M. tuberculosis (n=36) 32 35 0.1
Other species (n=5) 4 5 0.5
Total (n=41) 36 40 0.1
All specimens
M. tuberculosis (n=84) 78 83 0.06
Other species (n=11) 10 11 0.5
Total(n=95) 88 94 0.03
Contamination
rate (respiratory
specimens)
1.5% 1.5% 1
Delay for
isolation (days)
22661 9 65 0.1
doi:10.1371/journal.pntd.0000083.t002
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For developing countries we estimated a labour cost ranging from
37 J to 50 J for 1,000 analyses. Demonstration of the cost-
effectiveness of blood-agar slants for the secure isolation of
mycobacteria is of particular importance for the management in
resource-limited countries where mycobacterial infections, chiefly
tuberculosis, are highly prevalent. The microscopic-observation
drug-susceptibility (MODS) assay has recently been demonstrated
to be a cost-effective assay for M. tuberculosis isolation in Peru,
costing an estimated 2 US$ per specimen [17]. The MODS assay
simply relies on low-power microscopic examination of inoculated
liquid medium and median time to culture positivity was
significantly shorter for MODS than for the automated mycobac-
terial culture. MODS, unlike blood agar slants, however requires
specific training [17].
Beyond standard laboratory equipment, automated mycobac-
terial culture requires computer-linked automated culture incuba-
tors and the servicing of sophisticated equipment which may not
be easily achieved in resource-limited countries. Indeed, as for
exemple, CSF specimens only are routinely cultured for M.
tuberculosis using egg-based medium in Laos (P. Newton,
personnal communication). The blood-agar method requires no
specific equipment and the same tube allows for the isolation of
non-mycobacterial bacteria and mycobacteria, thus even reducing
the cost per analysis that we estimated. Contrary to the MODS
assay, labour costs were not found to be significantly higher for the
blood-agar method than the automated BACTEC method. Blood-
agar method requires only an incubator, basic equipment in
clinical laboratory and aseptically collected mammalian blood and
NaOH which can be readily obtained in any country. This is of
concern for resource-limited countries where blood-agar, but not
specialized media, are available and mycobacterial infections are
highly prevalent. In addition, developed countries require
simplified procedures for the broadest spectrum of isolation and
growth of organisms. Blood agar is a versatile medium routinely
used in the laboratory for the isolation of both rapidly growing and
fastidious bacteria from most clinical specimens. Prolonged
incubation on blood agar has been advocated for the isolation of
Bartonella species from clinical specimens such as lymph nodes and
mycobacteria including M. tuberculosis appeared to be the first
group of organisms to be isolated from such diseased specimens
[18].
This study suggests that the isolation of mycobacteria on blood
agar is not an anecdotal finding and that contamination of culture
is not a frequent problem. We submit that if incubated for
sufficiently long time ordinary blood agar is a cost-effective
method for culturing Mycobacterium species from various clinical
specimens. Blood agar was not only inexpensive, but was also
more sensitive and as rapid as the reference automated method
used in industrialised countries.
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